✦ LIBER ✦

Long-term follow-up of 163 consecutive patients treated with isolated limb perfusion for in-transit metastases of malignant melanoma

✍ Scribed by Olofsson, Roger; Mattsson, Jan; Lindnér, Per

Book ID: 125509065
Publisher: Informa plc
Year: 2013
Tongue: English
Weight: 532 KB
Volume: 29
Category: Article
ISSN: 0265-6736
DOI: 10.3109/02656736.2013.802374

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term outcome of isolated limb perfu

Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases

✍ J. P. Deroose; D. J. Grünhagen; A. N. van Geel; J. H. W. de Wilt; A. M. M. Egger 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 1 views

Long-Term Results of Melphalan-Based Iso

Long-Term Results of Melphalan-Based Isolated Limb Perfusion With or Without Low-Dose TNF for In-Transit Melanoma Metastases

✍ Carlo Riccardo Rossi; Sandro Pasquali; Simone Mocellin; Antonella Vecchiato; Luc 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 195 KB

Melan-A specific CD8+ T lymphocytes afte

Melan-A specific CD8+ T lymphocytes after hyperthermic isolated limb perfusion: A pilot study in patients with in-transit metastases of malignant melanoma

✍ Olofsson, Roger; Lindberg, Erika; Karlsson-Parra, Alex; Lindnér, Per; Mattsson, 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 443 KB

Adverse Events in the Long-Term Follow-U

Adverse Events in the Long-Term Follow-Up of Patients Treated With Samarium Sm 153 Lexidronam for Osseous Metastases

✍ Anthony J. Paravati; Andrea L. Russo; Candice Aitken 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Re-Evaluation of Toxicity and Long-Term

Re-Evaluation of Toxicity and Long-Term Follow-Up of Isolated Lung Perfusion With Melphalan in Patients With Resectable Pulmonary Metastases: A Phase I and Extension Trial

✍ Marco J.J.H. Grootenboers; Franz M.N.H. Schramel; Wim J. van Boven; Bart P. van 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Long-term follow-up in patients treated

Long-term follow-up in patients treated with methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) for transitional cell carcinoma of urinary bladder: Cause for concern

✍ John P. Connor; Carl A. Olsson; Mitchell C. Benson; Ihor S. Sawczuk; Frederick R 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 340 KB